Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block vs Peritubal Infiltration in PCNL
NCT02764008Phase 4Completed
- Sponsor
- Atatürk University
- Start
- May 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in nephrolithiasis, sponsored by Atatürk University. Primary endpoint: Total opioid consumption at 24 hours. Started May 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT02764008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02764008.